Integer Holdings Misses Q3 2026 Estimates as KKR Deal Costs Mount
As seen on the 24/7 Wall St. homepage on October 29, 2026.
Integer missed on both lines, with adjusted EPS falling well short of expectations as electrophysiology product headwinds and costs tied to the pending $5.7 billion KKR buyout piled up. There is no outlook and no conference call, so the deal closing by year-end is the only story left for holders.
Continue ReadingShow less
Integer Holdings posted adjusted EPS of $1.34 for Q3 2026, missing expectations on both earnings and revenue. The dual miss reverses a streak of beats stretching back through 2025.
Two forces hit the top line at once: Cardio and Vascular sales dropped 5.1% on headwinds from two new electrophysiology products, and the Other Markets segment fell after Integer exited its Portable Medical business.
Sponsored
Transaction expenses tied to the pending $5.7 billion KKR acquisition, restructuring charges, ERP implementation costs, and fixed asset impairments all ran through the income statement, pulling adjusted EBITDA down to $87.9 million.
Integer stockholders approved the KKR deal on October 21, 2026, and with the transaction expected to close by year-end the company provided no outlook and held no conference call. For holders, what matters now is whether the acquisition clears its remaining regulatory hurdles on schedule.
Mentioned: ITGR